Insider Shareholders with Direct Ownership of Cin Cor Pharma, Inc. (CINC)
This section provides a comprehensive overview of the insiders with direct ownership of Cin Cor Pharma, Inc. (CINC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CinCor Pharma, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Cin Rx Pharma, Llc
> 10% Shareholder |
1,222,530 | 0 | 3,630,103 $0 | 1 |
Jan 11, 2022
Added 25.19%
|
|
Catherine Pearce
Chief Operating Officer |
28,985 | 159,146 | 155,149 $0 | 5 |
Jan 26, 2023
Added 8.82%
|
|
Mason Freeman
Chief Medical Officer |
42,500 | 42,500 | 42,500 $0 | 4 |
Jan 26, 2023
Added 48.48%
|
|
James Healy
Director |
29,411 | 29,411 | 29,411 $0 | 2 |
Aug 05, 2022
Added 50.0%
|
|
Michael Wayne Kalb
EVP & Chief Financial Officer |
202,437 | 202,437 | 0 $0 | 3 |
Feb 24, 2023
Reduced 100.0%
|
|
Marc De Garidel
Chief Executive Officer |
212,500 | 212,500 | 0 $0 | 3 |
Feb 24, 2023
Reduced 100.0%
|